The functional impact of MSI1 in cancer was studied on the basis of loss– as well as gain–of function studies, including shRNA–, siRNA–, morpholino–directed impairment of MSI1 abundance and its overexpression [14,19,22,23,25,47,65,69,75]. The gene discussed is MSI1; the disease is cancer.